ArticleHealth promotion and chronic disease prevention in Canada : research, policy and practice2026
A mixed-methods approach to understanding pharmacists' experiences with the CANRISK diabetes risk questionnaire and user guide.
Article in Health promotion and chronic disease prevention in Canada : research, policy and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe Canadian Diabetes Risk Questionnaire (CANRISK) is a validated tool for diabetes risk screening, but the extent of its uptake and implementation by Canadian pharmacists has not been assessed. We aimed to describe the current use of the CANRISK tool and user guide among pharmacists, identify facilitators and barriers, and provide solutions to improve uptake.
methodsWe used a mixed-methods approach comprising an initial quantitative online survey followed by qualitative interviews with pharmacists to allow for a deeper understanding of their experiences. Descriptive statistics were used to analyze the survey data and thematic analysis was used to analyze the interview data.
resultsWe found that 89% of pharmacists surveyed provided diabetes counselling on a daily or weekly basis, but more than half (55%) were not aware of CANRISK and its user guide. Of those who were aware, 60% indicated that they rarely or never used CANRISK. Five overarching themes were identified in the qualitative component. The facilitators to CANRISK uptake included pharmacist's interest, diabetes clinic days/awareness campaigns, and patient-provider relationship. However, there are barriers to its implementation, including time constraints, competing priorities, financial pressures, staff shortages, and limited understanding of the tool's usefulness.
conclusionThis paper found that CANRISK use was limited, and that support is needed to address the barriers for the successful implementation of CANRISK in pharmacies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.